Gibb DM - Search Results

1

Menson EN, Walker AS, Gibb DM. Menson EN, et al. Among authors: gibb dm. Lancet. 2004 Dec 18-31;364(9452):2176-7. doi: 10.1016/S0140-6736(04)17581-8. Lancet. 2004. PMID: 15610796 No abstract available.

2

Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.

De Rossi A, Walker AS, De Forni D, Gibb DM; Paediatric European Network for Treatment of AIDS (PENTA). De Rossi A, et al. Among authors: gibb dm. AIDS. 2002 Sep 27;16(14):1961-3. doi: 10.1097/00002030-200209270-00015. AIDS. 2002. PMID: 12351958 No abstract available.

3

Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.

Walker AS, Doerholt K, Sharland M, Gibb DM; Collaborative HIV Paediatric Study (CHIPS) Steering Committee. Walker AS, et al. Among authors: gibb dm. AIDS. 2004 Sep 24;18(14):1915-24. doi: 10.1097/00002030-200409240-00007. AIDS. 2004. PMID: 15353977

4

Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.

Mulenga V, Ford D, Walker AS, Mwenya D, Mwansa J, Sinyinza F, Lishimpi K, Nunn A, Gillespie S, Zumla A, Chintu C, Gibb DM; CHAP Trial Team. Mulenga V, et al. Among authors: gibb dm. AIDS. 2007 Jan 2;21(1):77-84. doi: 10.1097/QAD.0b013e3280114ed7. AIDS. 2007. PMID: 17148971 Clinical Trial.

5

Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.

L'homme RF, Kabamba D, Ewings FM, Mulenga V, Kankasa C, Thomason MJ, Walker AS, Chintu C, Burger DM, Gibb DM. L'homme RF, et al. Among authors: gibb dm. AIDS. 2008 Mar 12;22(5):557-65. doi: 10.1097/QAD.0b013e3282f4a208. AIDS. 2008. PMID: 18316996 Clinical Trial.

6

The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.

Ryan M, Griffin S, Chitah B, Walker AS, Mulenga V, Kalolo D, Hawkins N, Merry C, Barry MG, Chintu C, Sculpher MJ, Gibb DM. Ryan M, et al. Among authors: gibb dm. AIDS. 2008 Mar 30;22(6):749-57. doi: 10.1097/QAD.0b013e3282f43519. AIDS. 2008. PMID: 18356605

7

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.

Oudijk JM, McIlleron H, Mulenga V, Chintu C, Merry C, Walker AS, Cook A, Gibb DM, Burger DM. Oudijk JM, et al. Among authors: gibb dm. AIDS. 2012 Jul 31;26(12):1523-8. doi: 10.1097/QAD.0b013e3283550e20. AIDS. 2012. PMID: 22546991 Clinical Trial.

8

The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK.

Donegan KL, Walker AS, Dunn D, Judd A, Pillay D, Menson E, Lyall H, Tudor-Williams G, Gibb DM; Collaborative HIV Paediatric Study; UK HIV Drug Resistance Database. Donegan KL, et al. Among authors: gibb dm. Antivir Ther. 2012;17(4):599-603. doi: 10.3851/IMP2015. Epub 2011 Dec 15. Antivir Ther. 2012. PMID: 22300840

9

Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.

Menson EN, Walker AS, Sharland M, Wells C, Tudor-Williams G, Riordan FA, Lyall EG, Gibb DM; Collaborative HIV Paediatric Study Steering Committee. Menson EN, et al. Among authors: gibb dm. BMJ. 2006 May 20;332(7551):1183-7. doi: 10.1136/bmj.332.7551.1183. BMJ. 2006. PMID: 16709991 Free PMC article.

10

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.

Kikaire B, Khoo S, Walker AS, Ssali F, Munderi P, Namale L, Reid A, Gibb DM, Mugyenyi P, Grosskurth H; DART Trial Team. Kikaire B, et al. Among authors: gibb dm. AIDS. 2007 Mar 30;21(6):733-7. doi: 10.1097/QAD.0b013e3280121801. AIDS. 2007. PMID: 17413694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters